Plenco 508-140 Flow: Product Reference
Product Description
Plenco 508-140 Flow was a phenolic molding compound manufactured by Plastics Engineering Company, commonly known as Plenco, a Wisconsin-based specialty plastics manufacturer that developed and produced a broad line of thermoset resin systems throughout much of the twentieth century. Phenolic compounds of this type were formulated as moldable thermosetting plastics — materials that, once cured under heat and pressure, formed rigid, dimensionally stable parts that could not be re-melted or reshaped. This characteristic made phenolic molding compounds highly attractive to industries requiring components capable of withstanding sustained mechanical stress, elevated temperatures, and chemical exposure.
The “Flow” designation in the product name referred to a specific rheological characteristic of the compound — its behavior during the molding process. Flow-grade phenolic compounds were engineered to move consistently and predictably within a mold cavity under defined conditions of heat and pressure, filling complex geometries without voids or incomplete fill. This property was critical for manufacturers producing precision components such as electrical connectors, switch housings, circuit breaker parts, industrial handles, pulleys, and mechanical hardware. Plenco supplied its molding compounds to original equipment manufacturers, fabricators, and industrial molders across a wide range of sectors, including electrical equipment manufacturing, automotive parts production, and general industrial applications.
Plenco operated as a significant domestic supplier of phenolic and other thermoset molding materials from the mid-twentieth century onward, and its product lines encompassed numerous numbered formulations tailored to specific performance requirements. Plenco 508-140 Flow represented one entry within that catalog, positioned to serve applications where controlled flow characteristics were required alongside the thermal and electrical insulating properties inherent to cured phenolic materials.
Asbestos Content
Phenolic molding compounds produced during portions of the twentieth century were commonly formulated with asbestos fiber as a functional filler or reinforcing agent. Asbestos served several roles within these compounds. As a filler, it reduced raw material costs while maintaining or improving certain mechanical properties. As a reinforcing fiber, chrysotile or other asbestos varieties contributed to the compound’s impact resistance, flexural strength, and dimensional stability under thermal cycling. Asbestos was also valued for its ability to improve the heat resistance and arc-resistance of phenolic parts used in electrical applications — a significant selling point for components intended for use in switching gear, motor controls, and related equipment.
Litigation records document allegations that Plenco 508-140 Flow contained asbestos as a component of its formulation. Plaintiffs alleged that asbestos fiber was incorporated into this phenolic compound during the manufacturing process, consistent with industry practices documented across the thermoset molding compound sector during the relevant production era. The specific fiber type, loading percentage, and formulation details pertaining to this particular product are subject to the evidentiary record developed in individual legal proceedings rather than publicly available technical documentation.
How Workers Were Exposed
Workers who handled, processed, or worked in proximity to phenolic molding compounds containing asbestos faced potential exposure through several occupational pathways. The nature and intensity of exposure varied depending on the specific task, the work environment, and the engineering controls — if any — that were in place.
Molding and Fabrication Operations: Industrial workers who operated compression molding, transfer molding, or injection molding equipment using phenolic compounds were among those potentially exposed. Phenolic molding compounds were typically supplied as powders, granules, or preforms. Loading these materials into molds, weighing and measuring charges, and handling bulk containers could release fine particulate, including any asbestos fiber present in the formulation, into the breathing zone of the worker.
Grinding, Deflashing, and Finishing: After molded parts were ejected from tooling, excess material — known as flash — required removal by grinding, sanding, or manual trimming. These operations on cured phenolic parts containing asbestos could generate respirable dust containing asbestos fibers. Workers performing deflashing, secondary machining, or surface finishing of phenolic components were potentially exposed through these processes.
Mixing and Compounding: Workers involved in mixing raw phenolic resin with fillers, reinforcements, and other additives prior to pelletizing or granulating the compound could encounter asbestos in its raw, unbound state — a condition associated with higher fiber release potential than working with fully cured material.
Maintenance and Material Handling Personnel: Maintenance workers servicing molding equipment, cleaning work areas, or handling waste material and scrap from phenolic molding operations also faced potential secondary or bystander exposure, particularly in facilities with inadequate ventilation or housekeeping practices.
Plaintiffs alleged that exposure to asbestos-containing phenolic compounds, including products attributed to Plenco, occurred in industrial settings without adequate warning of the associated health hazards, and without sufficient engineering controls or respiratory protection to limit fiber inhalation. Litigation records document claims that this exposure contributed to the development of asbestos-related diseases including mesothelioma, asbestosis, and lung cancer among affected workers.
Documented Trust Fund / Legal Options
Plenco 508-140 Flow is classified as a Tier 2 product for purposes of legal remedy documentation, meaning that claims associated with this product have proceeded through civil litigation rather than through an established asbestos bankruptcy trust fund. No Plenco asbestos trust fund has been identified in publicly available trust fund documentation at the time of this writing, and individuals seeking compensation for injuries allegedly associated with this product would pursue claims through the civil tort system.
Civil Litigation Pathway: Litigation records document that plaintiffs have named Plenco and alleged exposure to its phenolic molding compounds, including asbestos-containing formulations, in personal injury lawsuits. These cases have been pursued in state court systems across the country, typically by plaintiffs or their survivors alleging diagnoses of mesothelioma, lung cancer, or other asbestos-related conditions. Plaintiffs alleged that Plenco, as the manufacturer of the compound, bore responsibility for failing to adequately warn of the hazards associated with asbestos-containing products and for placing a defective product into commerce.
Identifying the Claim: A successful civil claim associated with Plenco 508-140 Flow generally requires establishing that the claimant was exposed to this specific product or to Plenco phenolic compounds as a category, that the exposure occurred in an occupational context, and that a qualifying asbestos-related diagnosis has been rendered by a licensed physician. Employment records, coworker testimony, product invoices, purchasing records, and facility documentation have all been used in litigation to establish product identification and exposure history.
Consulting Legal Counsel: Individuals who worked in industrial molding, fabrication, or manufacturing environments where Plenco phenolic compounds were used, and who have received an asbestos-related diagnosis, are encouraged to consult with an attorney experienced in asbestos personal injury litigation. Statutes of limitations governing these claims vary by state and typically run from the date of diagnosis or discovery of the asbestos-related condition rather than the date of exposure. Early consultation is advisable to preserve legal options.
This article is provided for informational and reference purposes only and does not constitute legal advice.